Source: Journal of Molecular and Cellular Cardiology. Unidade: EEFE
Subjects: FARMACOLOGIA, FISIOLOGIA, INSUFICIÊNCIA CARDÍACA, CARDIOLOGIA
ABNT
FERREIRA, Julio Cesar Batista e BRUM, Patricia Chakur e MOCHLY-ROSEN, Daria. 'beta' IIPKC and 'épsilon' PKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure. Journal of Molecular and Cellular Cardiology, v. 51, p. 479-484, 2011Tradução . . Disponível em: http://ac.els-cdn.com/S0022282810003998/1-s2.0-S0022282810003998-main.pdf?_tid=3405d86058fa5d8193f1f43cdbe58326&acdnat=1342119331_155a76a1dea8dac900622cc4ec7fbc0e. Acesso em: 18 ago. 2024.APA
Ferreira, J. C. B., Brum, P. C., & Mochly-Rosen, D. (2011). 'beta' IIPKC and 'épsilon' PKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure. Journal of Molecular and Cellular Cardiology, 51, 479-484. doi:10.1016/j.yjmcc.2010.10.020NLM
Ferreira JCB, Brum PC, Mochly-Rosen D. 'beta' IIPKC and 'épsilon' PKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure [Internet]. Journal of Molecular and Cellular Cardiology. 2011 ; 51 479-484.[citado 2024 ago. 18 ] Available from: http://ac.els-cdn.com/S0022282810003998/1-s2.0-S0022282810003998-main.pdf?_tid=3405d86058fa5d8193f1f43cdbe58326&acdnat=1342119331_155a76a1dea8dac900622cc4ec7fbc0eVancouver
Ferreira JCB, Brum PC, Mochly-Rosen D. 'beta' IIPKC and 'épsilon' PKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure [Internet]. Journal of Molecular and Cellular Cardiology. 2011 ; 51 479-484.[citado 2024 ago. 18 ] Available from: http://ac.els-cdn.com/S0022282810003998/1-s2.0-S0022282810003998-main.pdf?_tid=3405d86058fa5d8193f1f43cdbe58326&acdnat=1342119331_155a76a1dea8dac900622cc4ec7fbc0e